Pfizer: New Life For Lipitor As Alzheimer’s Treatment
August 28, 2007 by Douglas A. McIntyreA new medical study shows that people who take statins, cholesterol-lowering drugs, appear to be less likely to develope Alzheimer’s, one of the most damaging and fastest growing diseases. Pfizer’s (PFE) Lipitor is the top selling statin, bringing in $10. According to Reuters, Bristol-Myers Squibb (BMY) Pravachol and Merck (MRK) Zocor are also in this category of drugs.
Lipitor went off-patent last year, opening it to competition from generics, and the market continues to be concerned about what this will do to Pfizer’s long term earnings.
Finding a new market for the drug could work wonders.
Douglas A. McIntyre
Sponsored: Attention Savvy Investors: Speak to 3 Financial Experts – FREE
Ever wanted an extra set of eyes on an investment you’re considering? Now you can speak with up to 3 financial experts in your area for FREE. By simply
clicking here you can begin to match with financial professionals who can help guide you through the financial decisions you’re making. And the best part? The first conversation with them is free.
Click here to match with up to 3 financial pros who would be excited to help you make financial decisions.